Literature DB >> 22122085

Epigenetic architecture and miRNA: reciprocal regulators.

Erik D Wiklund1, Jørgen Kjems, Susan J Clark.   

Abstract

Deregulation of epigenetic and miRNA pathways are emerging as key events in carcinogenesis. miRNA genes can be epigenetically regulated and miRNAs can themselves repress key enzymes that drive epigenetic remodeling. Epigenetic and miRNA functions are thus tightly interconnected and crucial for maintaining correct local and global genomic architecture as well as gene-expression patterns, yet the underlying molecular mechanisms and their widespread effects remain poorly understood. Owing to the tissue specificity, versatility and relative stability of miRNAs, these small ncRNAs are considered especially promising in clinical applications, and their biogenesis and function is subject of active research. In this article, the current status of epigenetic miRNA regulation is summarized and future therapeutic prospects in the field are discussed with a focus on cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22122085     DOI: 10.2217/epi.10.51

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  21 in total

1.  Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.

Authors:  Edward A Ratovitski
Journal:  Cell Cycle       Date:  2014-01-06       Impact factor: 4.534

2.  Ovarian Toxicity and Epigenetic Mechanisms of Phthalates and Their Metabolites.

Authors:  Hua-Hua Jiang; Yao-Yao Du; Yu-Feng Li
Journal:  Curr Med Sci       Date:  2021-04-20

Review 3.  MicroRNAs in biliary diseases.

Authors:  Patricia Munoz-Garrido; Maite García-Fernández de Barrena; Elizabeth Hijona; Miguel Carracedo; José J G Marín; Luis Bujanda; Jesús M Banales
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

4.  Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers.

Authors:  Hyuna Sung; Howard H Yang; Han Zhang; Qi Yang; Nan Hu; Ze-Zhong Tang; Hua Su; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; William Wheeler; Carol Giffen; Laurie Burdett; Zhaoming Wang; Maxwell P Lee; Stephen J Chanock; Sanford M Dawsey; Neal D Freedman; Christian C Abnet; Alisa M Goldstein; Kai Yu; Philip R Taylor; Paula L Hyland
Journal:  Int J Epidemiol       Date:  2015-04-27       Impact factor: 7.196

5.  Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Haruhiro Yamashita; Sailesh Surapureddi; Ramesh C Kovi; Sachin Bhusari; Thai Vu Ton; Jian-Liang Li; Keith R Shockley; Shyamal D Peddada; Kevin E Gerrish; Cynthia V Rider; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

6.  miR-26a-5p suppresses nasopharyngeal carcinoma progression by inhibiting PTGS2 expression.

Authors:  Binlin Cai; Xiu Qu; Dan Kan; Yi Luo
Journal:  Cell Cycle       Date:  2022-01-25       Impact factor: 4.534

Review 7.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

8.  microRNA Regulation and Its Consequences in Cancer.

Authors:  Sonya Parpart; Xin Wei Wang
Journal:  Curr Pathobiol Rep       Date:  2012-12-18

Review 9.  Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2014-07-05       Impact factor: 6.730

Review 10.  Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.

Authors:  Lin Tan; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-06-29       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.